Filter Results:
(150)
Show Results For
- All HBS Web (150)
- Faculty Publications (19)
Show Results For
- All HBS Web (150)
- Faculty Publications (19)
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
wait until they're safer? So those are all the things the MMRF has to work on is making the drugs safer, making them. Better tolerated, so you have better quality of life. And then understanding the... View Details
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
innovation efforts traditionally have focused on new products such as drugs and devices, survey respondents ranked process improvements in care delivery as the most promising opportunity for improving the cost and View Details
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
industries, including: a novel enzymatic RNA synthesis platform, an immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat... View Details
- 27 Mar 2012
- First Look
First Look: March 27
are determined not only by the quality of the product, but also by the incentives of the media outlet providing the review. For example, a media outlet may have the incentive to provide favorable coverage to certain authors or to slant... View Details
Keywords: Carmen Nobel
- Web
Skydeck - Alumni
recipient and finance veteran Naina Lal Kidwai (MBA 1982) on her second act as chairman and founder of the India Sanitation Coalition, an organization focused on improving India’s water quality and health outcomes Home Grown Naveen Tewari... View Details
- 27 Feb 2019
- Research & Ideas
The Hidden Cost of a Product Recall
Evidence from Medical Device Firms, released in January. Bigger recalls, bigger reactions Using 13 years of US Food and Drug Administration data and a novel set of competitor classification algorithms, the team created a detailed history... View Details
- Web
Winners & Runners-Up | New Venture Competition
Venture Competition Runner-Up, Business Track: Sanso Sanso is helping drug manufacturers produce life-saving biologics more efficiently, in order to deliver cheaper drugs to patients worldwide. Team: Narek... View Details
- 15 Jan 2013
- First Look
First Look: January 15
paper: http://ssrn.com/abstract=2190963 Which Does More to Determine the Quality of Corporate Governance in Emerging Economies, Firms or Countries? Authors:Hugill, Andrea, and Jordan Siegel Abstract Scholars of corporate governance have... View Details
Keywords: Sean Silverthorne
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
disorder immediately. HHT has no cure or FDA approved treatment yet, and severe complications can arise if it is not properly diagnosed or treated. People living with rare diseases, like HHT, suffer from increased mortality and reduced View Details
- 01 Jun 2015
- Research & Ideas
The Surprising Benefits of Oversharing
whether they would admit that they used drugs on a job application; a different set of participants acting as prospective employers were asked whom they'd rather hire, someone who admitted using drugs, or someone who chose not to answer.... View Details
Keywords: by Michael Blanding
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
would make payments to health care providers on a risk-adjusted per-enrolled basis instead of a fee-for-service basis—as a tool to mitigate risks involved with centralized pricing and rate-setting. Evidence suggests that capitation can drive payers to compete on View Details
- 21 Oct 2015
- Research & Ideas
How to Predict if a New Business Idea is Any Good
industry like drug development, it’s not like you can just switch from one disease to another disease,” she says. While R&D-intensive ventures can shift the application of their underlying technology, Shu continues, the fact they are... View Details
- 07 Jan 2002
- Research & Ideas
How Marketing Can Reduce Worldwide Poverty
on-the-ground advocacy—to go get a free eye exam or a blood pressure check-up. Easy. Your basic principles of sales and promotion will carry the day. If your charge is minimizing smoking or drug use, well, your job becomes rather more... View Details
Keywords: by Martha Lagace
- Web
Industry Information - Alumni
biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provide local expertise along with a global perspective. BioSpace Leading online community for industry news and... View Details
- 06 Oct 2020
- Blog Post
2+2 Where Are They Now Spotlight: Curtis Wu (MBA 2018)
Can you describe your role?I currently work at Amgen Inc at their global HQ in Southern California. Amgen is the largest independent biotechnology company in the world by revenue and our top medicines include autoimmune drug Enbrel, white... View Details
- 08 Mar 2016
- First Look
March 8, 2016
often work directly with the companies they study. I then survey the factors that influence the quality of UGC. Quality is influenced by factors including promotional content, peer effects between... View Details
Keywords: Sean Silverthorne
- 17 Jun 2019
- Blog Post
Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program
and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug... View Details
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
players, poor customer service, and regional variations in quality of care. "By virtually any standard, it's an underperforming industry," says Richard Hamermesh, faculty chair of Harvard Business School's recently formed... View Details
- 01 Sep 2008
- News
Mara Aspinall
presidential candidates have acknowledged the need for change, and that opens up an opportunity to shift from payment based on activity to payment based on quality and outcome mea-sures. One part of that will be improving the efficacy of... View Details